Finland· FI-REL-REL770
Artergin
A ergoloid mesylates product containing dihydroergotoxini mesilas (lat.), registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ergoloid mesylates is registered in 2 of 19 countries.
Countries holding a registration under ATC C04AE01 (ergoloid mesylates), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Ergoloid mesylates · ATC C04AE01
2 / 19 countries
- Czechiaprice
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Dihydroergotoxini mesilas (lat.)
- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- C04AE01
- ATC class
- Ergoloid mesylates
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C04AE01
Ergoloid mesylates, as other registers publish it.
- FinlandArterginOrion Corporation Orion Pharma
- FinlandArterginOrion Corporation Orion Pharma
- FinlandHyderginParanova Oy
- FinlandHyderginDefiante Farmaceutica S.A.
- FinlandHyderginDefiante Farmaceutica S.A.
- FinlandHyderginOrifarm Oy
- CzechiaSECATOXIN FORTETEVA Czech Industries s.r.o., Opava-Komárov
- CzechiaSECATOXIN FORTETeva B.V., Haarlem
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdf2d736-d1ac-4952-9363-481cb856b6c9 GET /v1/drugs/fdf2d736-d1ac-4952-9363-481cb856b6c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "3",
"form": "tabletti",
"route": null,
"ddd_unit": "mg",
"strength": "1.5 mg",
"atc_label": "ergoloidimesylaatit",
"ma_number": "6077",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL770",
"authorised_at": "1970-09-02"
}See everything about ergoloid mesylates.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.